The risk of hepatobiliary cancer with metabolic syndrome: a nested case-control study

Jul-17

AUTHORS : Dr Shyam Menon, The Royal Wolverhampton Nhs Trust, Wolverhampton Road, Wolverhampton, West Midlands WV10 0QP – No email found – Profile: https://www.royalwolverhampton.nhs.uk/services/service-directory-a-z/gastroenterology/endoscopy/meet-the-team/dr-shyam-menon/ – No email found for Dr Ray Mathew, The Royal Wolverhampton NHS Trust – Profile: https://www.nuffieldhealth.com/consultants/dr-ray-mathew

JOURNAL : Gut

REFERENCE: 66(S2):A94-A95

DOI : 10.1136/gutjnl-2017-314472.183

The risk of hepatobiliary cancer with metabolic syndrome: a nested case-control study

More publications

Evaluating the potential impact of lifestyle‑based behavior change interventions delivered at the time of colorectal cancer screening

Association of Adherence to Endocrine Therapy Among Patients With Breast Cancer and Potential Drug-Drug Interactions

Low-dose aspirin does not lower the risk of colorectal cancer in patients with type 2 diabetes taking metformin